Anti-obesity effects of yellow catfish protein hydrolysate on mice fed a 45% kcal high-fat diet

International Journal of Molecular Medicine

Volumn 40, Issue 3, 2017, Pages 784-800

  Kim, Mi Ryung ^a   Kim, Joo Wan ^b   Park, Jeong Been ^a   Hong, Yong Ki ^c   Ku, Sae Kwang ^d   Choi, Jae Suk ^a  

^a Silla University   (South Korea)

^b Aribio   (South Korea)

^c Pukyong National University   (South Korea)

^d Daegu Haany University   (South Korea)

Author keywords

Anti obesity effects; Protein hydrolysates; Pseudobagrus fulvidraco; Yellow catfish

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CATALASE; CHOLESTEROL; CREATININE; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PROTEIN HYDROLYSATE; SIMVASTATIN; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; UREA; FISH PROTEIN;

ABDOMINAL FAT; ABDOMINAL WALL; ADIPOCYTE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOBESITY ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIET INDUCED OBESITY; DRUG ACTIVITY; EXPERIMENTAL STEATOHEPATITIS; FAT PAD; FECES ANALYSIS; FEMALE; HYPERTROPHY; KIDNEY TUBULE DISORDER; LIPID PEROXIDATION; LIVER HYPERTROPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; WEIGHT GAIN; ANIMAL; BLOOD; CATFISH; CHEMICALLY INDUCED; DIET THERAPY; FAT INTAKE; INSTITUTE FOR CANCER RESEARCH MOUSE; OBESITY; PHARMACOLOGY;

ANIMALS; CATFISHES; DIETARY FATS; FEMALE; FISH PROTEINS; MICE; MICE, INBRED ICR; OBESITY; PROTEIN HYDROLYSATES;

EID: 85026651600     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2017.3063     Document Type: Article

References (80)

1. Wendel AA, Purushotham A, Liu LF and Belury MA: Conjugated linoleic acid fails to worsen insulin resistance but induces hepatic steatosis in the presence of leptin in ob/ob mice. J Lipid Res 49: 98-106, 2008.
2. Tilg H and Moschen AR: Adipocytokines: Mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6: 772-783, 2006.
3. James PT, Leach R, Kalamara E and Shayeghi M: The worldwide obesity epidemic. Obes Res 9 (Suppl 4): 228S-233S, 2001.
4. Zimmet P: The burden of type 2 diabetes: are we doing enough? Diabetes Metab 29: 6S9-6S18, 2003.
5. Kunitomi M, Wada J, Takahashi K, Tsuchiyama Y, Mimura Y, Hida K, Miyatake N, Fujii M, Kira S, Shikata K, et al: Relationship between reduced serum IGF-I levels and accumulation of visceral fat in Japanese men. Int J Obes Relat Metab Disord 26: 361-369, 2002.
6. Hida K, Wada J, Eguchi J, Zhang H, Baba M, Seida A, Hashimoto I, Okada T, Yasuhara A, Nakatsuka A, et al: Visceral adipose tissue-derived serine protease inhibitor: A unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci USA 102: 10610-10615, 2005.
7. Lebovitz HE: Insulin resistance: Definition and consequences. Exp Clin Endocrinol Diabetes 109 (Suppl 2): S135-S148, 2001.
8. Goldstein BJ: Insulin resistance as the core defect in type 2 diabetes mellitus. Am J Cardiol 90: 3G-10G, 2002.
9. Angulo P: Nonalcoholic fatty liver disease. N Engl J Med 346: 1221-1231, 2002.
10. Kadowaki T and Yamauchi T: Adiponectin and adiponectin receptors. Endocr Rev 26: 439-451, 2005.
11. Inzucchi SE: Oral antihyperglycemic therapy for type 2 diabetes: Scientific review. JAMA 287: 360-372, 2002.
12. Jung YM, Lee SH, Lee DS, You MJ, Chung IK, Cheon WH, Kwon YS, Lee YJ and Ku SK: Fermented garlic protects diabetic, obese mice when fed a high-fat diet by antioxidant effects. Nutr Res 31: 387-396, 2011.
13. Kim CM, Yi SJ, Cho IJ and Ku SK: Red-koji fermented red ginseng ameliorates high fat diet-induced metabolic disorders in mice. Nutrients 5: 4316-4332, 2013.
14. Föger B: Lipid lowering therapy in type 2 diabetes. Wien Med Wochenschr 161: 289-296, 2011.
15. Desai CS, Martin SS and Blumenthal RS: Non-cardiovascular effects associated with statins. BMJ 349: g3743, 2014.
16. Wei P, Grimm PR, Settles DC, Balwanz CR, Padanilam BJ and Sansom SC: Simvastatin reverses podocyte injury but not mesangial expansion in early stage type 2 diabetes mellitus. Ren Fail 31: 503-513, 2009.
17. Wang L, Duan G, Lu Y, Pang S, Huang X, Jiang Q and Dang N: The effect of simvastatin on glucose homeostasis in streptozotocin induced type 2 diabetic rats. J Diabetes Res 2013: 274986, 2013.
18. American Diabetes Association: Management of dyslipidemia in adults with diabetes. Diabetes Care 25: S74-S77, 2002.
19. Wald NJ and Law MR: A strategy to reduce cardiovascular disease by more than 80%. BMJ 326: 1419, 2003.
20. Abbas AM and Sakr HF: Simvastatin and vitamin E effects on cardiac and hepatic oxidative stress in rats fed on high fat diet. J Physiol Biochem 69: 737-750, 2013.
21. Cui B, Liu S, Lin X, Wang J, Li S, Wang Q and Li S: Effects of Lycium barbarum aqueous and ethanol extracts on high-fat-diet induced oxidative stress in rat liver tissue. Molecules 16: 9116-9128, 2011.
22. Simsek Ozek N, Bal IB, Sara Y, Onur R and Severcan F: Structural and functional characterization of simvastatin-induced myotoxicity in different skeletal muscles. Biochim Biophys Acta 1840: 406-415, 2014.
23. Magni P, Macchi C, Morlotti B, Sirtori CR and Ruscica M: Risk identification and possible countermeasures for muscle adverse effects during statin therapy. Eur J Intern Med 26: 82-88, 2015.
24. López-Barrios L, Gutiérrez-Uribe JA and Serna-Saldívar SO: Bioactive peptides and hydrolysates from pulses and their potential use as functional ingredients. J Food Sci 79: R273-R283, 2014.
25. Nesse KO, Nagalakshmi AP, Marimuthu P and Singh M: Efficacy of a fish protein hydrolysate in malnourished children. Indian J Clin Biochem 26: 360-365, 2011.
26. Ryan JT, Ross RP, Bolton D, Fitzgerald GF and Stanton C: Bioactive peptides from muscle sources: Meat and fish. Nutrients 3: 765-791, 2011.
27. Kim KM, Chang UJ, Kang DH, Kim JM, Choi YM and Suh HJ: Yeast hydrolysate reduces body fat of dietary obese rats. Phytother Res 18: 950-953, 2004.
28. Wergedahl H, Gudbrandsen OA, Rast TH and Berge RK: Combination of fish oil and fish protein hydrolysate reduces the plasma cholesterol level with a concurrent increase in hepatic cholesterol level in high-fat-fed Wistar rats. Nutrition 25: 98-104, 2009.
29. Liu X, Zhang M, Zhang C and Liu C: Angiotensin converting enzyme (ACE) inhibitory, antihypertensive and antihyperlipidaemic activities of protein hydrolysates from Rhopilema esculentum. Food Chem 134: 2134-2140, 2012.
30. Mun JM, Ok HM and Kwon O: Corn gluten hydrolysate and capsaicin have complimentary actions on body weight reduction and lipid-related genes in diet-induced obese rats. Nutr Res 34: 458-465, 2014.
31. Gu Z, Wang J, Li M, Zhang J, Ke X and Gong X: Morphological and genetic differences of Trypanosoma in some Chinese freshwater fishes: Difficulties of species identification. Parasitol Res 101: 723-730, 2007.
32. Chen QL, Luo Z, Zheng JL, Li XD, Liu CX, Zhao YH and Gong Y: Protective effects of calcium on copper toxicity in Pelteobagrus fulvidraco: Copper accumulation, enzymatic activities, histology. Ecotoxicol Environ Saf 76: 126-134, 2012.
33. Yun SN, Moon SJ, Ko SK, Im BO and Chung SH: Wild ginseng prevents the onset of high-fat diet induced hyperglycemia and obesity in ICR mice. Arch Pharm Res 27: 790-796, 2004.
34. Lee JW, Lee KW, Lee SW, Kim IH and Rhee C: Selective increase in pinolenic acid (all-cis-5,9,12-18:3) in Korean pine nut oil by crystallization and its effect on LDL-receptor activity. Lipids 39: 383-387, 2004.
35. Kim UH, Yoon JH, Li H, Kang JH, Ji HS, Park KH, Shin DH, Park HY and Jeong TS: Pterocarpan-enriched soy leaf extract ameliorates insulin sensitivity and pancreatic β-cell proliferation in type 2 diabetic mice. Molecules 19: 18493-18510, 2014.
36. Folch J, Lees M and Sloane Stanley GH: A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226: 497-509, 1957.
37. Allain CC, Poon LS, Chan CSG, Richmond W and Fu PC: Enzymatic determination of total serum cholesterol. Clin Chem 20: 470-475, 1974.
38. McGowan MW, Artiss JD, Strandbergh DR and Zak B: A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem 29: 538-542, 1983.
39. Kang SJ, Lee JE, Lee EK, Jung DH, Song CH, Park SJ, Choi SH, Han CH, Ku SK and Lee YJ: Fermentation with Aquilariae Lignum enhances the anti-diabetic activity of green tea in type II diabetic db/db mouse. Nutrients 6: 3536-3571, 2014.
40. Kavutcu M, Canbolat O, Oztürk S, Olcay E, Ulutepe S, Ekinci C, Gökhun IH and Durak I: Reduced enzymatic antioxidant defense mechanism in kidney tissues from gentamicin-treated guinea pigs: Effects of vitamins E and C. Nephron 72: 269-274, 1996.
41. Jamall IS and Smith JC: Effects of cadmium on glutathione peroxidase, superoxide dismutase, and lipid peroxidation in the rat heart: A possible mechanism of cadmium cardiotoxicity. Toxicol Appl Pharmacol 80: 33-42, 1985.
42. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
43. Sedlak J and Lindsay RH: Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 25: 192-205, 1968.
44. Aebi H: Catalase. In: Methods in Enzymatic Analysis. Bergmeyer HU (ed). Academic Press, New York, pp673-686, 1974.
45. Sun Y, Oberley LW and Li Y: A simple method for clinical assay of superoxide dismutase. Clin Chem 34: 497-500, 1988.
46. Kawakami S, Han KH, Nakamura Y, Shimada K, Kitano T, Aritsuka T, Nagura T, Ohba K, Nakamura K and Fukushima M: Effects of dietary supplementation with betaine on a nonalcoholic steatohepatitis (NASH) mouse model. J Nutr Sci Vitaminol (Tokyo) 58: 371-375, 2012.
47. Lee HS, Chang JH and Ku SK: An immunohistochemical study of the pancreatic endocrine cells of the ddN mouse. Folia Histochem Cytobiol 48: 387-393, 2010.
48. Levene A: Pathological factors influencing excision of tumours in the head and neck. Part I. Clin Otolaryngol Allied Sci 6: 145-151, 1981.
49. Ludbrook J: Update: Microcomputer statistics packages. A personal view. Clin Exp Pharmacol Physiol 24: 294-296, 1997.
50. Surwit RS, Kuhn CM, Cochrane C, McCubbin JA and Feinglos MN: Diet-induced type II diabetes in C57BL/6J mice. Diabetes 37: 1163-1167, 1988.
51. Thupari JN, Kim EK, Moran TH, Ronnett GV and Kuhajda FP: Chronic C75 treatment of diet-induced obese mice increases fat oxidation and reduces food intake to reduce adipose mass. Am J Physiol Endocrinol Metab 287: E97-E104, 2004.
52. Park SH, Ko SK and Chung SH: Euonymus alatus prevents the hyperglycemia and hyperlipidemia induced by high-fat diet in ICR mice. J Ethnopharmacol 102: 326-335, 2005.
53. DiGirolamo M, Fine JB, Tagra K and Rossmanith R: Qualitative regional differences in adipose tissue growth and cellularity in male Wistar rats fed ad libitum. Am J Physiol 274: R1460-R1467, 1998.
54. Morange PE, Lijnen HR, Alessi MC, Kopp F, Collen D and Juhan-Vague I: Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity. Arterioscler Thromb Vasc Biol 20: 1150-1154, 2000.
55. Fujita H, Fujishima H, Koshimura J, Hosoba M, Yoshioka N, Shimotomai T, Morii T, Narita T, Kakei M and Ito S: Effects of antidiabetic treatment with metformin and insulin on serum and adipose tissue adiponectin levels in db/db mice. Endocr J 52: 427-433, 2005.
56. Mitchell M, Armstrong DT, Robker RL and Norman RJ: Adipokines: Implications for female fertility and obesity. Reproduction 130: 583-597, 2005.
57. Tasso F, Clop J and Sarles H: The interaction of ethanol, dietary lipids and proteins on the rat pancreas. II. Ultrastructural study. Digestion 4: 23-34, 1971.
58. Wilson JS, Korsten MA, Leo MA and Lieber CS: Combined effects of protein deficiency and chronic ethanol consumption on rat pancreas. Dig Dis Sci 33: 1250-1259, 1988.
59. Gartner LP and Hiatt JL: Color Textbook of Histology. 3rd edition. Saunders, Philadelphia, pp417-422, 2007.
60. Hyland NP, Rybicka JM, Ho W, Pittman QJ, Macnaughton WK and Sharkey KA: Adaptation of intestinal secretomotor function and nutrient absorption in response to diet-induced obesity. Neurogastroenterol Motil 22: 602-e171, 2010.
61. Bertrand RL, Senadheera S, Markus I, Liu L, Howitt L, Chen H, Murphy TV, Sandow SL and Bertrand PP: A Western diet increases serotonin availability in rat small intestine. Endocrinology 152: 36-47, 2011.
62. Snedeker SM and Hay AG: Do interactions between gut ecology and environmental chemicals contribute to obesity and diabetes? Environ Health Perspect 120: 332-339, 2012.
63. Chen X, Osborne MC, Rybczynski PJ, Zeck R, Yang M, Xu J, Zhou L, Cryan E, Tang Y and Demarest KT: Pharmacological profile of a novel, non-TZD PPARgamma agonist. Diabetes Obes Metab 7: 536-546, 2005.
64. Kamada T, Hata J, Kusunoki H, Ito M, Tanaka S, Kawamura Y, Chayama K and Haruma K: Eradication of Helicobacter pylori increases the incidence of hyperlipidaemia and obesity in peptic ulcer patients. Dig Liver Dis 37: 39-43, 2005.
65. Zdrenghea D, Gligor E, Ossian V and Pop D: The effect of simvastatin associated with ranitidine and alcohol upon serum lipids. Rom J Intern Med 42: 143-148, 2004.
66. Quine SD and Raghu PS: Effects of (-)-epicatechin, a flavonoid on lipid peroxidation and antioxidants in streptozotocin-induced diabetic liver, kidney and heart. Pharmacol Rep 57: 610-615, 2005.
67. Sodikoff CH: Laboratory profiles of small animal diseases. A guide to laboratory diagnosis. 2nd edition. Mosby Inc., St. Louise, pp1-36, 1995.
68. Garg MC, Singh KP and Bansal DD: Effect of vitamin C supplementation on oxidative stress in experimental diabetes. Indian J Exp Biol 35: 264-266, 1997.
69. Ceriello A, Quatraro A and Giugliano D: New insights on non-enzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications. Diabet Med 9: 297-299, 1992.
70. Collier A, Wilson R, Bradley H, Thomson JA and Small M: Free radical activity in type 2 diabetes. Diabet Med 7: 27-30, 1990.
71. Giugliano D, Ceriello A and Paolisso G: Oxidative stress and diabetic vascular complications. Diabetes Care 19: 257-267, 1996.
72. Comporti M: Lipid peroxidation and cellular damage in toxic liver injury. Lab Invest 53: 599-623, 1985.
73. Lee YM, Gweon OC, Seo YJ, Im J, Kang MJ, Kim MJ and Kim JI: Antioxidant effect of garlic and aged black garlic in animal model of type 2 diabetes mellitus. Nutr Res Pract 3: 156-161, 2009.
74. Jung UJ, Park YB, Kim SR and Choi MS: Supplementation of persimmon leaf ameliorates hyperglycemia, dyslipidemia and hepatic fat accumulation in type 2 diabetic mice. PLoS One 7: e49030, 2012.
75. Odabasoglu F, Cakir A, Suleyman H, Aslan A, Bayir Y, Halici M and Kazaz C: Gastroprotective and antioxidant effects of usnic acid on indomethacin-induced gastric ulcer in rats. J Ethnopharmacol 103: 59-65, 2006.
76. Cheeseman KH and Slater TF: An introduction to free radical biochemistry. Br Med Bull 49: 481-493, 1993.
77. Erejuwa OO, Sulaiman SA, Wahab MS, Salam SK, Salleh MS and Gurtu S: Comparison of antioxidant effects of honey, glibenclamide, metformin, and their combinations in the kidneys of streptozotocin-induced diabetic rats. Int J Mol Sci 12: 829-843, 2011.
78. Wu D, Wen W, Qi CL, Zhao RX, Lü JH, Zhong CY and Chen YY: Ameliorative effect of berberine on renal damage in rats with diabetes induced by high-fat diet and streptozotocin. Phytomedicine 19: 712-718, 2012.
79. Chung SI, Rico CW and Kang MY: Comparative study on the hypoglycemic and antioxidative effects of fermented paste (doenjang) prepared from soybean and brown rice mixed with rice bran or red ginseng marc in mice fed with high fat diet. Nutrients 6: 4610-4624, 2014.
80. Wu D, Zheng N, Qi K, Cheng H, Sun Z, Gao B, Zhang Y, Pang W, Huangfu C, Ji S, et al: Exogenous hydrogen sulfide mitigates the fatty liver in obese mice through improving lipid metabolism and antioxidant potential. Med Gas Res 5: 1, 2015.